Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Cardiology

Side Effects of Midodrine & Fludrocortisone for POTS

At a Glance

Midodrine and fludrocortisone treat POTS but require careful safety routines. Midodrine can cause dangerously high blood pressure if you lie flat, so you must stay upright after a dose. Fludrocortisone can deplete potassium, requiring regular blood tests to safely monitor your electrolytes.

In this answer

3 sections

01

Midodrine: The “Do Not Lie Down” Rule

02

Fludrocortisone: Monitoring Potassium and Fluids

03

Ongoing Safety Checks

Midodrine and fludrocortisone are common medications used to manage Postural Orthostatic Tachycardia Syndrome (POTS), but both require specific safety routines to prevent side effects [1][2]. The most critical side effect of midodrine is supine hypertension (dangerously high blood pressure when lying flat), which means patients must stay upright after taking it [3]. For fludrocortisone, the main concern is hypokalemia (low potassium levels) and fluid shifts, requiring routine blood tests to keep electrolytes balanced [4][5].

Midodrine: The “Do Not Lie Down” Rule

Midodrine works by constricting blood vessels to help push blood back up to the heart and brain [1]. However, because it actively raises blood pressure, it significantly increases the risk of supine hypertension [3]. This means your blood pressure can spike to unsafe levels if you lie completely flat while the medication is active in your system.

To manage this safety risk, patients taking midodrine typically follow specific behaviors:

  • Avoid lying flat: You must avoid the supine (flat) position while the medication is active [6].
  • Strategic dosing times: Doctors generally avoid scheduling doses late in the day to ensure the medication wears off before you go to sleep [7]. Typically, the last dose is taken at least 3 to 4 hours before bedtime [8]. Because POTS can cause brain fog, setting daily phone alarms for your last dose can help prevent accidental nighttime hypertension.
  • Elevate the head of your bed: Non-pharmacological strategies like raising the head of your bed (using bed risers or a full mattress wedge, rather than just stacking pillows which can strain your neck) can help alleviate supine hypertension risks [9][8].

In addition to blood pressure changes, midodrine commonly causes paresthesia (scalp tingling or itching) and piloerection (goosebumps) [10][1]. While these sensations can feel strange, they are harmless expected effects. Some patients may also experience urinary retention or urgency [11][12], or reflex bradycardia (a slower heart rate) [13].

Fludrocortisone: Monitoring Potassium and Fluids

Fludrocortisone is a mineralocorticoid medication that helps your body hold onto sodium and water, which increases your overall blood volume to alleviate POTS symptoms [2]. Because of how it affects your kidneys, it commonly causes sodium retention and carries a significant risk of depleting your body’s potassium—a condition known as hypokalemia [4][14].

Because potassium is critical for normal heart and muscle function, patients taking fludrocortisone require regular, individualized monitoring:

  • Routine blood tests: Your care team will need to periodically check your serum electrolyte concentrations to ensure your potassium hasn’t dropped too low [15][5].
  • Watch for fluid retention: The medication is designed to help you retain water, but too much can lead to peripheral edema (swelling in the legs and ankles) or rapid weight gain. You should monitor for visible swelling and track sudden weight changes [15][5].
  • Blood pressure checks: Regular blood pressure monitoring is essential to ensure the medication is stabilizing your symptoms without causing hypertension [5][16].
  • Potassium replacement: Depending on your lab results, your doctor will advise if an oral potassium supplement is necessary [17]. While some patients try to eat more potassium-rich foods, there are no established guidelines for dietary potassium alone in POTS [18]. Ask your doctor what approach is right for you.
  • Sodium and fluid goals: Because fludrocortisone helps you hold onto sodium, you must clarify with your doctor whether you should maintain, increase, or decrease your daily salt and fluid loading targets [19].

Ongoing Safety Checks

Because these medications require specific patient actions—like modifying your resting posture or scheduling routine blood draws—it is critical to establish a clear management plan [15]. Always confirm exactly how long you need to wait before lying down after midodrine, and make sure you know when your next electrolyte check is scheduled for fludrocortisone.

Common questions in this guide

Why can't I lie flat after taking midodrine?
Midodrine works by constricting blood vessels to raise your blood pressure, which helps with POTS symptoms. If you lie completely flat while the medication is active, your blood pressure can spike to dangerously high levels, a condition called supine hypertension.
Why do I need routine blood tests while taking fludrocortisone?
Fludrocortisone helps your body retain sodium and water, but it can also cause your body to lose potassium. Regular blood tests are necessary to ensure your potassium levels do not drop dangerously low and to check your overall electrolyte balance.
Is it normal for my scalp to tingle while taking midodrine?
Yes, scalp tingling, scalp itching, and goosebumps are very common and harmless side effects of midodrine. While these sensations can feel unusual, they are an expected reaction to the medication and not a cause for panic.
Do I still need to eat extra salt and drink lots of fluids if I take fludrocortisone?
Because fludrocortisone already helps your body hold onto sodium, your previous salt and fluid goals may need to change. You should ask your doctor whether to maintain, increase, or decrease your daily dietary sodium and fluid intake while on this medication.
Why are my ankles swelling after starting fludrocortisone?
Fludrocortisone is designed to help you retain water, but too much fluid retention can cause peripheral edema, which appears as swelling in your legs and ankles. You should monitor for visible swelling and track sudden weight changes to share with your doctor.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my target blood pressure, and what reading should I consider an emergency while on these medications?
  2. 2.Exactly how many hours before bedtime should I take my final dose of midodrine?
  3. 3.How often will I need to have my blood drawn to check my potassium levels?
  4. 4.Do I need to change my daily sodium and fluid goals now that I am starting fludrocortisone?
  5. 5.Should I take a potassium supplement, or can I manage my potassium levels through diet alone?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Are There FDA-Approved Medications for POTS?Does Blood Pressure Drop With POTS? POTS vs. OH ExplainedDoes POTS Go Away? Long-Term Prognosis & RecoveryHow Does Ivabradine Work for POTS? Uses & Side EffectsHow Much Salt Per Day for POTS? Daily Sodium GuidelinesHow to Exercise with POTS: The CHOP & Levine ProtocolsHow to Stop a POTS Flare-Up: Fast Rescue StrategiesHow Do You Use Pacing and Spoon Theory for POTS Fatigue?What Are the Different Subtypes of POTS? (Key Symptoms)What Causes Secondary POTS? Triggers & Conditions ExplainedWhat Is Coat Hanger Pain in POTS? Causes and ReliefWhat Is the Best Compression for POTS Relief?What Is the POTS Trifecta? hEDS, MCAS, & POTS ExplainedPOTS Tilt Table Test: What to Expect & How to PrepareWhy Are POTS Symptoms Worse in the Morning?Why Do Hot Showers Trigger POTS Symptoms & Dizziness?Why Is POTS Frequently Misdiagnosed as Anxiety?Why Is Recumbent Exercise Best for POTS?How to Get POTS Accommodations at Work & School

References

References (19)
  1. 1

    Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review of studies before and during the COVID-19 pandemic.

    Pierson BC, Apilado K, Franzos MA, et al.

    Frontiers in neurology 2024; (15()):1515486 doi:10.3389/fneur.2024.1515486.

    PMID: 39882369
  2. 2

    Suspected COVID-19 mRNA Vaccine-Induced Postural Orthostatic Tachycardia Syndrome.

    Maharaj N, Swarath S, Seecheran R, et al.

    Cureus 2023; (15(1)):e34236 doi:10.7759/cureus.34236.

    PMID: 36852364
  3. 3

    Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.

    Chen JJ, Han Y, Tang J, et al.

    The Annals of pharmacotherapy 2018; (52(12)):1182-1194 doi:10.1177/1060028018786954.

    PMID: 29972032
  4. 4

    Trick or Treat? Licorice-Induced Hypokalemia: A Case Report.

    Benge E, Shah P, Yamaguchi L, Josef V

    Cureus 2020; (12(11)):e11656 doi:10.7759/cureus.11656.

    PMID: 33391895
  5. 5

    Plasma Renin Measurements are Unrelated to Mineralocorticoid Replacement Dose in Patients With Primary Adrenal Insufficiency.

    Pofi R, Prete A, Thornton-Jones V, et al.

    The Journal of clinical endocrinology and metabolism 2020; (105(1)) doi:10.1210/clinem/dgz055.

    PMID: 31613957
  6. 6

    Blood pressure regulation in autonomic failure by dietary sodium, blood volume and posture.

    Biaggioni I

    Autonomic neuroscience : basic & clinical 2021; (236()):102891 doi:10.1016/j.autneu.2021.102891.

    PMID: 34634681
  7. 7

    Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension.

    Isaacson SH, Dashtipour K, Mehdirad AA, Peltier AC

    Current neurology and neuroscience reports 2021; (21(4)):18 doi:10.1007/s11910-021-01104-3.

    PMID: 33687577
  8. 8

    Orthostatic hypotension in older people: considerations, diagnosis and management.

    Dani M, Dirksen A, Taraborrelli P, et al.

    Clinical medicine (London, England) 2021; (21(3)):e275-e282 doi:10.7861/clinmed.2020-1044.

    PMID: 34001585
  9. 9

    Study protocol for the Heads-Up trial: a phase II randomized controlled trial investigating head-up tilt sleeping to alleviate orthostatic intolerance in Parkinson's Disease and parkinsonism.

    van der Stam AH, de Vries NM, Shmuely S, et al.

    BMC neurology 2024; (24(1)):4 doi:10.1186/s12883-023-03506-x.

    PMID: 38166676
  10. 10

    Effect of Alpha-1-Adrenergic Agonist, Midodrine for the Management of Long-Standing Neurogenic Shock in Patient with Cervical Spinal Cord Injury: A Case Report.

    Kim T, Jwa CS

    Korean journal of neurotrauma 2015; (11(2)):147-50 doi:10.13004/kjnt.2015.11.2.147.

    PMID: 27169082
  11. 11

    Midodrine initiation criteria, dose titration, and adverse effects when administered to treat shock: A systematic review and semi-quantitative analysis.

    Puissant MM, Armstrong KJ, Riker RR, et al.

    Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) 2025; (11(1)):5-22 doi:10.2478/jccm-2025-0007.

    PMID: 40017476
  12. 12

    Putting midodrine on the MAP: An approach to liberation from intravenous vasopressors in vasodilatory shock.

    Smith SE, Peters NA, Floris LM, et al.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2022; (79(13)):1047-1055 doi:10.1093/ajhp/zxac069.

    PMID: 35235946
  13. 13

    Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study.

    Smith W, Wan H, Much D, et al.

    Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2016; (26(4)):269-77 doi:10.1007/s10286-016-0363-9.

    PMID: 27372462
  14. 14

    Use of Fludrocortisone for Hyperkalemia in Chronic Kidney Disease Not Yet on Dialysis.

    Lee EK, Yang WS

    Electrolyte & blood pressure : E & BP 2024; (22(1)):8-15 doi:10.5049/EBP.2024.22.1.8.

    PMID: 38957547
  15. 15

    Performance of renin assays in selecting fludrocortisone dose in children with adrenal disorders.

    Morris TJ, Whatmore A, Hamilton L, et al.

    Endocrine connections 2024; (13(2)).

    PMID: 38165389
  16. 16

    Mineralocorticoid replacement therapy in salt-wasting congenital adrenal hyperplasia.

    Lang K, Quinkler M, Kienitz T

    Clinical endocrinology 2024; (101(4)):346-358 doi:10.1111/cen.14959.

    PMID: 37564007
  17. 17

    The Cl-/HCO3- exchanger pendrin is downregulated during oral co-administration of exogenous mineralocorticoid and KCl in patients with primary aldosteronism.

    Wu A, Wolley MJ, Wu Q, et al.

    Journal of human hypertension 2021; (35(10)):837-848 doi:10.1038/s41371-020-00439-7.

    PMID: 33173144
  18. 18

    Novel pharmacotherapeutic options for the treatment of postural orthostatic tachycardia syndrome.

    Lyonga Ngonge A, Nyange C, Ghali JK

    Expert opinion on pharmacotherapy 2024; (25(2)):181-188 doi:10.1080/14656566.2024.2319224.

    PMID: 38465412
  19. 19

    Postural orthostatic tachycardia syndrome: pathophysiology, management, and experimental therapies.

    Narasimhan B, Aggarwal D, Satish P, et al.

    Expert opinion on investigational drugs 2022; (31(10)):1017-1025 doi:10.1080/13543784.2022.2121697.

    PMID: 36094001

This page provides educational information about the side effects of common POTS medications. Always consult your prescribing doctor or cardiologist for personalized medical advice, lab monitoring, and medication management.

Get notified when new evidence is published on Postural Orthostatic Tachycardia Syndrome (POTS).

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.